CHINA JO-JO DRUGSTORES HOLDI (CJJD) Fundamental Analysis & Valuation
NASDAQ:CJJD • KYG2124G1203
Current stock price
1.52 USD
-0.09 (-5.59%)
Last:
This CJJD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. CJJD Profitability Analysis
1.1 Basic Checks
- CJJD had negative earnings in the past year.
- CJJD had a negative operating cash flow in the past year.
- In the past 5 years CJJD always reported negative net income.
- CJJD had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- CJJD has a worse Return On Assets (-5.93%) than 77.50% of its industry peers.
- The Return On Equity of CJJD (-26.03%) is worse than 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.93% | ||
| ROE | -26.03% | ||
| ROIC | N/A |
ROA(3y)-10.23%
ROA(5y)-8.83%
ROE(3y)-52.56%
ROE(5y)-43.49%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- CJJD has a Gross Margin of 20.24%. This is in the lower half of the industry: CJJD underperforms 60.00% of its industry peers.
- CJJD's Gross Margin has declined in the last couple of years.
- CJJD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 20.24% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.87%
GM growth 5Y-2.92%
2. CJJD Health Analysis
2.1 Basic Checks
- CJJD does not have a ROIC to compare to the WACC, probably because it is not profitable.
- CJJD has more shares outstanding than it did 1 year ago.
- CJJD has more shares outstanding than it did 5 years ago.
- CJJD has a worse debt/assets ratio than last year.
2.2 Solvency
- Based on the Altman-Z score of 0.37, we must say that CJJD is in the distress zone and has some risk of bankruptcy.
- CJJD's Altman-Z score of 0.37 is on the low side compared to the rest of the industry. CJJD is outperformed by 82.50% of its industry peers.
- CJJD has a Debt/Equity ratio of 1.54. This is a high value indicating a heavy dependency on external financing.
- CJJD has a Debt to Equity ratio of 1.54. This is in the lower half of the industry: CJJD underperforms 77.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.54 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.37 |
ROIC/WACCN/A
WACC3.25%
2.3 Liquidity
- A Current Ratio of 1.05 indicates that CJJD should not have too much problems paying its short term obligations.
- CJJD has a Current ratio of 1.05. This is comparable to the rest of the industry: CJJD outperforms 47.50% of its industry peers.
- CJJD has a Quick Ratio of 1.05. This is a bad value and indicates that CJJD is not financially healthy enough and could expect problems in meeting its short term obligations.
- CJJD has a better Quick ratio (0.77) than 67.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.05 | ||
| Quick Ratio | 0.77 |
3. CJJD Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 91.08% over the past year.
- CJJD shows a decrease in Revenue. In the last year, the revenue decreased by -4.87%.
- Measured over the past years, CJJD shows a small growth in Revenue. The Revenue has been growing by 7.52% on average per year.
EPS 1Y (TTM)91.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.01%
Revenue 1Y (TTM)-4.87%
Revenue growth 3Y5.1%
Revenue growth 5Y7.52%
Sales Q2Q%-9.44%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. CJJD Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for CJJD. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. CJJD Dividend Analysis
5.1 Amount
- CJJD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
CJJD Fundamentals: All Metrics, Ratios and Statistics
NASDAQ:CJJD (3/3/2025, 8:22:01 PM)
1.52
-0.09 (-5.59%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)03-01 2022-03-01/amc
Earnings (Next)N/A N/A
Inst Owners0.37%
Inst Owner Change0%
Ins Owners40.89%
Ins Owner Change0%
Market Cap9.39M
Revenue(TTM)147.13M
Net Income(TTM)-5.59M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.06 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.44 | ||
| P/tB | 0.51 | ||
| EV/EBITDA | N/A |
EPS(TTM)-2.38
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-2.42
FCFYN/A
OCF(TTM)-2.24
OCFYN/A
SpS23.81
BVpS3.47
TBVpS2.98
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.93% | ||
| ROE | -26.03% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 20.24% | ||
| FCFM | N/A |
ROA(3y)-10.23%
ROA(5y)-8.83%
ROE(3y)-52.56%
ROE(5y)-43.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.87%
GM growth 5Y-2.92%
F-Score3
Asset Turnover1.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.54 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 118.59% | ||
| Cap/Sales | 0.78% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.05 | ||
| Quick Ratio | 0.77 | ||
| Altman-Z | 0.37 |
F-Score3
WACC3.25%
ROIC/WACCN/A
Cap/Depr(3y)61.55%
Cap/Depr(5y)65.76%
Cap/Sales(3y)0.33%
Cap/Sales(5y)0.68%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)91.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.01%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.87%
Revenue growth 3Y5.1%
Revenue growth 5Y7.52%
Sales Q2Q%-9.44%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y69.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-163.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-151.88%
OCF growth 3YN/A
OCF growth 5YN/A
CHINA JO-JO DRUGSTORES HOLDI / CJJD Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for CHINA JO-JO DRUGSTORES HOLDI?
ChartMill assigns a fundamental rating of 1 / 10 to CJJD.
What is the valuation status of CHINA JO-JO DRUGSTORES HOLDI (CJJD) stock?
ChartMill assigns a valuation rating of 0 / 10 to CHINA JO-JO DRUGSTORES HOLDI (CJJD). This can be considered as Overvalued.
Can you provide the profitability details for CHINA JO-JO DRUGSTORES HOLDI?
CHINA JO-JO DRUGSTORES HOLDI (CJJD) has a profitability rating of 0 / 10.